论文部分内容阅读
目的对上皮型中晚期卵巢癌采用TP方案配合腹腔化疗治疗的临床疗效进行研究分析。方法 60例上皮型中晚期卵巢癌患者,随机分为研究组和对照组,每组30例。对照组采用CAP方案进行化疗,研究组通过TP方案联合腹腔化疗的方法进行治疗,比较两组疗效。结果研究组总有效率86.67%,对照组总有效率70.00%,比较差异具有统计学意义(P<0.05);两组Ⅱ、Ⅲ度骨髓抑制较多见,Ⅳ度较为少见;患者的肝功能有不同程度转氨酶上升,两组间比较,差异无统计学意义(P>0.05)。结论通过TP方案配合腹腔化疗对上皮型中晚期卵巢癌疾病患者进行治疗后,患者的病情可以得到有效缓解,且毒副反应也较轻,可以使患者的生活质量得到提升,值得大量在临床中推广运用。
Objective To study the clinical efficacy of TP regimen in combination with intraperitoneal chemotherapy for advanced epithelial ovarian cancer. Methods Sixty patients with epithelial advanced ovarian cancer were randomly divided into study group and control group with 30 cases in each group. The control group was treated with CAP regimen. The study group was treated with TP regimen combined with intraperitoneal chemotherapy. The curative effect was compared between the two groups. Results The total effective rate was 86.67% in the study group and 70.00% in the control group, with significant difference between the two groups (P <0.05). The bone marrow suppression of Ⅱ and Ⅲ degrees was more common in the two groups and rare in Ⅳ. The liver function There are varying degrees of transaminases increased, no significant difference between the two groups (P> 0.05). Conclusion TP regimen combined with intraperitoneal chemotherapy for advanced epithelial ovarian cancer patients after treatment, the patient’s condition can be effectively alleviated, and the side effects are mild, can improve the quality of life of patients, it is worth a lot in the clinical Promote the use of.